Filana Therapeutics (FLNA) Current Leases (2019 - 2022)
Filana Therapeutics (FLNA) posted Current Leases of $104000.0 for Q4 2022, up 1.96% on a QoQ basis from $102000.0 in Q3 2022, and up 7.22% year-over-year from $97000.0 in Q4 2021.
Analysis
Filana Therapeutics (FLNA) Current Leases (2019 - 2022) Analysis & Trends
Filana Therapeutics has reported Current Leases for 4 years, with the latest figure at $104000.0 in Q4 2022.
- On a quarterly basis, Current Leases rose 7.22% year-over-year to $104000.0 in Q4 2022; TTM through Dec 2022 was $104000.0, a 7.22% increase from a year earlier, with the FY2022 full-year figure at $104000.0, up 7.22% from the prior year.
- Current Leases was $104000.0 for Q4 2022 at Filana Therapeutics, up from $102000.0 in the prior quarter.
- The five-year high for Current Leases was $104000.0 in Q4 2022, with the low at $45000.0 in Q2 2020.
- Average Current Leases over 4 years is $85125.0, with a median of $90000.0 recorded in 2019.
- The sharpest annual moves came in 2020 and 2021: Current Leases plunged 50.0% in 2020, then jumped 106.67% in 2021.
- Over 4 years, Current Leases stood at $90000.0 in 2019, then plunged by 35.56% to $58000.0 in 2020, then surged by 67.24% to $97000.0 in 2021, then gained by 7.22% to $104000.0 in 2022.
- The last three Current Leases figures came in at $104000.0 (Q4 2022), $102000.0 (Q3 2022), and $100000.0 (Q2 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 12.38 Mn |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 104,000.00 |
| Sep 30, 2022 | 102,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 97,000.00 |
| Sep 30, 2021 | 95,000.00 |
| Jun 30, 2021 | 93,000.00 |
| Mar 31, 2021 | 84,000.00 |
| Dec 31, 2020 | 58,000.00 |
| Sep 30, 2020 | 58,000.00 |
| Jun 30, 2020 | 45,000.00 |
| Mar 31, 2020 | 67,000.00 |
| Dec 31, 2019 | 90,000.00 |
| Sep 30, 2019 | 90,000.00 |
| Jun 30, 2019 | 90,000.00 |
| Mar 31, 2019 | 90,000.00 |